Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastoma.

ARC 100 - Cortice Biosci

Avastin (bevacizumab) - Roche

http://www.ncbi.nlm.nih.gov/pubmed/38327681

George Farmer; Lori Cappello; Louis B Nabors; Mayank Rao; Nimish Mohile; Paul J Duic; Samuel A Goldlust; Samuel Singer; Sandra L Silberman; Sigmund Hsu; Tara Benkers

Feb 8, 2024